期刊文献+

HPLC-RID法测定盐酸帕洛诺司琼注射液中甘露醇的含量测定

Determination of the Mannitol as a Excipient in Palonosetron Hydrochloride for Injection by HPLC-RID
下载PDF
导出
摘要 目的:建立高效液相色谱-示差折光检测法(HPLC-RID)来测定盐酸帕洛诺司琼注射液中辅料甘露醇的含量。方法:使用Carbomix Ca-NP作为填充剂的色谱柱,流动相是纯化水,流速0.5 mL/min,T_(柱温)=80℃,T_(检测)=50℃。结果:得出线性回归公式为y=5.9966X+0.0909,R^(2)=0.9997。研究结果揭示,甘露醇在2.42382~5.65558 mg/mL的浓度范围内展现出很好的线性关系,其精密度RSD达到0.67%;而重复性的平均含量为41.2308 mg/mL,在6个供试品中,其含量的RSD为0.42%;平均回收率为99.69%,其RSD为0.58%(n=9)。定量限和检出限为323.176 ng和121.1911 ng。6个批次的样品含量测定分别为41.176,41.3023,41.4692,41.5302,41.1616,41.2308(mg/mL),RSD=0.38%。结论总结来说,这种方法具有很高的专一性和精密度稳定性,准确性也相当高,因此可以作为测定盐酸帕洛诺司琼注射液中甘露醇含量的有效手段。 To develop an HPLC-RID technique for measuring mannitol levels in palosetron hydrochloride injections.The technique employed was High-performance liquid chromatography using a robust cation calcium exchange column containing Carbomix Ca-NP,with water serving as the mobile phase,a flow rate of 0.5 mL/min,a column temperature of 80℃,and a detection temperature of 50℃.Findings:the formula for linear regression stood at y=5.9966x+0.0909,with an R^(2) value of 0.9997.Findings indicated a strong linear correlation between mannitol and the range of 2.42382 mg/mL to 5.65558 mg/mL,with a precision RSD of 0.67%,a repeatability average of 41.2308 mg/mL,and a 0.42%RSD for six samples,and an average recovery rate of 99.69%with a 0.58%RSD(N=9).Quantification and detection thresholds stood at 323.176 ng and 121.1911 ng in that order.Across six separate batches,the recorded values were 41.176,41.3023,41.4692,41.5302,41.1616,41.2308(mg/mL),with an RSD of 0.38%.Conclusion:The technique is precise,reliable,and precise,suitable for measuring mannitol in palosetron hydrochloride injections.
作者 王璐 田甜 曹桂红 Wang Lu;Tian Tian;Cao Guihong(Institute for Food and Drug Control in Guizhou,Guiyang 550001,China)
出处 《广东化工》 CAS 2024年第12期160-162,共3页 Guangdong Chemical Industry
基金 2015年国家药品标准提高项目(271)。
关键词 盐酸帕洛诺司琼注射液 甘露醇 含量测定 高效液相-示差折光 injecting Palonosetron hydrochloride mannitol assessing content HPLC-RID
  • 相关文献

参考文献7

二级参考文献67

  • 1刘明亮,郭慧元.新喹诺酮类抗菌药甲磺酸帕珠沙星[J].中国新药杂志,2004,13(12):1164-1168. 被引量:12
  • 2林清强,叶锦林.新型5-HT3受体拮抗剂帕洛诺司琼[J].中国科技信息,2005(11):157-157. 被引量:12
  • 3张启明,李慧义.色谱分析中面积归一化法测定有关物质的弊与利[J].中国药品标准,2005,6(4):45-46. 被引量:14
  • 4吕庆淮,修文华,吴忠联.帕洛诺司琼的合成[J].中国新药杂志,2007,16(13):1027-1030. 被引量:1
  • 5Kowalezyk BA,Dyson NH.Hydrogenation of a chiral 1H-benz[de]isoquinolin-l-one and an equilibration usin8 palladium catalyst[J].Org Process Res Dev,1997,1 (2):117-120.
  • 6中国药典.二部[S].2010:凡例ⅩⅦ.
  • 7BERGER J,ROBIN D,RICHARD M,et al.Tricyclic 5-HT3 Receptor Antagonists:USP,5 202 333[P].1993-04-13.
  • 8ANDREWS P L,BHANDARI P.The 5-Hydroxtryptamine Receptor Antagonists as Antiemetics:Preclinical Evaluation and Mechanism of Action[J].Eur J Cancer,1993,29A(suppl 1):11-16.
  • 9KOWALCZYK B A.Total Synthesis of RS-42358and Analogs Using Lateral Lithiation[J].Synthesis,2000,(8):1113-1116.
  • 10JACOB B,ROBIN C D.Preparation of 2-Azabicycloalkyl-1 H-benz-[de]-isoquinolin-1-ones and Related Compounds as 5-HT3 Antangonists:EP,0 430 190[P].1990-11-27.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部